The vaccine against dengue fever has been ordered and will arrive next week at the InmiSpallanzani in Rome where it will be possible to obtain it.
Visit and vaccine are at the user's expense.
The vaccine, specifies the structure, which is among the first centers to receive the doses, will be administered in the Tropical Diseases Clinic with a reservation at the Institute's Cup or by writing to amministrazioneSPALLANZANI@inmi.it., specifies the Inmi.
Last September, AIFA gave the green light to the single vaccine for the prevention of the disease approved in Italy, even for those who have not had previous exposure to the virus and without the need to carry out a pre-vaccination test, as was specified at the time of approval. .
The dengue vaccine produced by Takeda is tetravalent, live attenuated, for prophylaxis against dengue disease, caused by any of the four serotypes of the virus.
It can be administered to subjects from 4 years of age and 2 doses are sufficient to achieve immunization.
Reproduction reserved © Copyright ANSA